The HIV Prevention Trials Network is a worldwide collaborative clinical trials network that develops and tests the safety and efficacy of interventions designed to prevent the transmission of HIV.
The HPTN was formed to conduct research on promising biomedical and behavioral HIV prevention strategies in populations and geographical regions Read More →
NEW! Melissa Turner and Georgette King -
Another StoryCorps Conversation. Hear more. . .
Ken Mayer and LaRon Nelson - A StoryCorps Conversation. Hear more. . .
What is HPTN 073? A new video featuring members of the protocol team study coordinators discussing how the study will work and why it is important
A poem written and performed by a study participant. Listen now
HPTN 061 Webinar - Lessons Learned and Next Steps- Watch now
HPTN Investigator Webinar
PrEP Adherence: Lessons from Clinical Trials, ART adherence and Biomedical Prevention Studies.
HPTN 073 Webinar - Launch of a new Black MSM PrEP Demonstration study - Watch now
Be sure to follow @HIVptn.
At the Crossroads of Prevention: HPTN Current and Future Network Priorities
Wafaa El-Sadr, Columbia University and Myron Cohen, University of North Carolina (May 2013). View now
Community-focused combination prevention from
an international and US perspective. Overview of HPTN 071 science
Richard Hayes, London School of Hygiene and Tropical Medicine (May 2013). View now
PrEP-Science and Implementation USA
Darrell Wheeler, Loyola University (May 2013) View now
PrEP Prospects in RSA: Where are we within our generalized epidemic?
Linda-Gail Bekker, Desmond Tutu HIV Centre (May 2013) View now